Surrogate endpoints, part 1 from definition to meta-analytic framework /

Testo
Series

Surrogate endpoints, part 2 further developments /

Testo
Series

Randomization, blinding and drug supply in interactive voice response trials

Testo
Series

The academic basis of primary health care

Testo

Ecological considerations for gene drive systems

Testo
Series

Guidance for responsible testing and implementation of gene-drive systems

Testo
Series

Data fusion examples in fusing metabolomics and transcriptomics data /

Testo
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 1 of 2 /

Testo
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Testo
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 2 of 2/

Testo
Series

Comparing transcriptomes of distant organisms the comparative ENCODE resource, part 1 of 2 /

Testo
Series

Comparing transcriptomes of distant organisms models of gene expression, part 2 of 2 /

Testo
Series

Linkage and sequence analysis in families

Testo
Series

Survival analysis

Testo
Series

Randomization in N-of-1 clinical trials is it possible to draw causal inferences from single-patient data /

Testo
Series

Introduction to systematic reviews for librarians

Testo
Series

Teixobactin kills pathogens without detectable resistance

Testo
Series (Antibiotic resistance)
Series (Small molecule drug discovery)

Manufacturing viral gene therapy vectors general approaches and challenges /

Testo
Series

Clinical proteomics in gastrointestinal cancers

Testo
Series

A concept for multi-marker approaches in clinical proteomics

Testo
Series